Ulta Beauty Maintains Its Luster Following a Robust Surge; Further Growth Anticipated.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 14 hours ago
0mins
Should l Buy ULTA?
Source: Barron's
Current Climate: The world is facing scandals, geopolitical tensions, extreme weather, and concerns about artificial intelligence.
Consumer Behavior: Despite these challenges, people continue to prioritize their appearance and beauty products.
Market Outlook: Ulta Beauty's stock is perceived as an attractive investment option amidst the prevailing uncertainties.
Industry Resilience: The beauty industry demonstrates resilience as consumers seek to maintain their self-image in difficult times.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ULTA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ULTA
Wall Street analysts forecast ULTA stock price to fall
22 Analyst Rating
15 Buy
6 Hold
1 Sell
Moderate Buy
Current: 689.420
Low
450.00
Averages
647.83
High
780.00
Current: 689.420
Low
450.00
Averages
647.83
High
780.00
About ULTA
Ulta Beauty, Inc. is a specialty United States beauty retailer and the premier beauty destination for cosmetics, fragrance, skincare products, haircare products and salon services. The Company operates approximately 1,451 retail stores across 50 states and distributes products through its Website, which includes a collection of tips, tutorials, and social content. The Company’s business includes a differentiated assortment of approximately 29,000 beauty products across a variety of categories and price points, as well as a variety of beauty services, including salon services, in more than 1,400 stores predominantly located in convenient, high-traffic locations. It also offers digital experiences delivered through its Website, Ulta.com, and its mobile applications. The Company’s brands include Ulta Beauty Collection, about-face, Ariana Grande, CHANEL, FENTY BEAUTY by Rihanna, It Cosmetics, LolaVie, OUAI, PAT McGRATH LABS, Tula, and NYX Professional Makeup.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Ulta Beauty Maintains Its Luster Following a Robust Surge; Further Growth Anticipated.
Current Climate: The world is facing scandals, geopolitical tensions, extreme weather, and concerns about artificial intelligence.
Consumer Behavior: Despite these challenges, people continue to prioritize their appearance and beauty products.
Market Outlook: Ulta Beauty's stock is perceived as an attractive investment option amidst the prevailing uncertainties.
Industry Resilience: The beauty industry demonstrates resilience as consumers seek to maintain their self-image in difficult times.
See More
Analysts Reaffirm Bullish Stance on Apple Stock
- Bullish Outlook for Apple: Joshua Brown, CEO of Ritholtz Wealth Management, remains bullish on Apple, with Wedbush analyst Dan Ives reiterating an Outperform rating and maintaining a $350 price target, reflecting strong market confidence in Apple's growth potential.
- AstraZeneca's Solid Earnings: AstraZeneca reported Q4 2025 sales of $15.5 billion, a 4% year-over-year increase, nearly matching the consensus of $15.49 billion, with adjusted earnings of $2.12 per share exceeding expectations of $2.09, showcasing its competitive strength in the pharmaceutical sector.
- VICI Properties Rating Downgrade: Scotiabank analyst Nicholas Yulico downgraded VICI Properties from Sector Outperform to Sector Perform and lowered the price target from $36 to $30, indicating a cautious outlook on the company's future performance.
- Ulta Beauty's Middle East Expansion: Ulta Beauty announced its first store opening in the UAE at Mall of the Emirates on January 29, reflecting its strategic expansion into international markets, which could enhance brand visibility and market share.
See More
Market Update: S&P 500 Declines and Upcoming CPI Data
- CPI Expectations: The consumer price index, set to be released at 8:30 a.m. ET on Friday, is expected to show a month-over-month increase of 0.3% and a year-over-year rise of 2.5%, which could significantly influence market sentiment and lead investors to reassess their risk appetite.
- Moderna Stock Fluctuations: Moderna's shares have surged 50% over the past three months, closing at $40.11 on Thursday, although this remains significantly lower than the pandemic peak of $497, indicating ongoing volatility in biotech stocks that investors are closely monitoring.
- Wendy's Stock Decline: Wendy's shares fell 7.7% on Thursday, down 55% from their 52-week high, highlighting the persistent pressures facing the fast-food industry, which may impact its future market performance.
- Retail Sector Dynamics: The Amplify Online Retail ETF dropped nearly 4% on Thursday, now down 19.5% from its September high, reflecting weakness in the retail market, especially after experiencing five consecutive weeks of declines, which could negatively affect overall consumer confidence.
See More
Ulta Beauty's Bullish Outlook, Arista Networks Faces Challenges
- Ulta Beauty Growth Potential: Ulta Beauty's stock has surged approximately 70% over the past 12 months, with its diverse product line ranging from mass-market to luxury brands attracting more consumers and enhancing market competitiveness.
- Increased Consumer Engagement: By boosting foot traffic, Ulta is driving organic sales growth, with retail sales up 3% year-over-year, indicating strong consumer demand for its products.
- Loyalty Program as Growth Driver: Ulta's loyalty program effectively attracts customers, increasing their shopping frequency and thereby enhancing market share and shareholder returns.
- Arista Networks Risks Emerging: Arista faces margin compression and high customer concentration issues; despite a backlog of $18.5 billion in orders, intense competition threatens its profitability.
See More
e.l.f. Beauty Surprises with Q3 Results, Stock Reversal Presents Buying Opportunity
- Significant Sales Growth: e.l.f. Beauty reported a 38% year-over-year sales increase in Q3 2023, reaching $489.5 million, significantly exceeding the analyst consensus of $460 million, indicating robust market demand and brand appeal.
- Enhanced Profitability: Adjusted earnings per share (EPS) surged 68% from $0.74 to $1.24, surpassing the analyst expectation of $0.72, reflecting the company's success in cost control and operational efficiency.
- Market Share Expansion: The e.l.f. brand gained 130 basis points in the mass cosmetics market, with U.S. and international revenues rising 36% and 44% respectively, despite weak consumption in the U.K., showcasing the brand's global appeal.
- Optimistic Outlook: The company raised its fiscal 2026 sales guidance to a growth range of 22% to 33%, expecting Rhode to contribute $260 million to $265 million in revenue, demonstrating confidence in future growth and strategic positioning.
See More
e.l.f. Beauty Reports Strong Q3 Results Exceeding Expectations
- Significant Sales Growth: e.l.f. Beauty's Q3 sales soared 38% year-over-year to $489.5 million, easily surpassing the analyst consensus of $460 million, indicating strong market demand and brand appeal.
- Improved Profitability: Adjusted earnings per share (EPS) surged 68% from $0.74 to $1.24, exceeding the analyst estimate of $0.72, reflecting the company's success in cost control and operational efficiency.
- Rhode Brand Contribution: The Rhode brand contributed $128 million in revenue during the quarter, bolstered by its successful launch at Sephora, further solidifying e.l.f.'s position in the rapidly growing beauty market.
- Optimistic Outlook: e.l.f. raised its fiscal 2026 sales guidance to an increase of 22% to 33%, with Rhode expected to contribute $260 million to $265 million in revenue, demonstrating the company's confidence in future growth and strategic positioning.
See More
Ulta Beauty Maintains Its Luster Following a Robust Surge; Further Growth Anticipated.
Current Climate: The world is facing scandals, geopolitical tensions, extreme weather, and concerns about artificial intelligence.
Consumer Behavior: Despite these challenges, people continue to prioritize their appearance and beauty products.
Market Outlook: Ulta Beauty's stock is perceived as an attractive investment option amidst the prevailing uncertainties.
Industry Resilience: The beauty industry demonstrates resilience as consumers seek to maintain their self-image in difficult times.
See More
Analysts Reaffirm Bullish Stance on Apple Stock
- Bullish Outlook for Apple: Joshua Brown, CEO of Ritholtz Wealth Management, remains bullish on Apple, with Wedbush analyst Dan Ives reiterating an Outperform rating and maintaining a $350 price target, reflecting strong market confidence in Apple's growth potential.
- AstraZeneca's Solid Earnings: AstraZeneca reported Q4 2025 sales of $15.5 billion, a 4% year-over-year increase, nearly matching the consensus of $15.49 billion, with adjusted earnings of $2.12 per share exceeding expectations of $2.09, showcasing its competitive strength in the pharmaceutical sector.
- VICI Properties Rating Downgrade: Scotiabank analyst Nicholas Yulico downgraded VICI Properties from Sector Outperform to Sector Perform and lowered the price target from $36 to $30, indicating a cautious outlook on the company's future performance.
- Ulta Beauty's Middle East Expansion: Ulta Beauty announced its first store opening in the UAE at Mall of the Emirates on January 29, reflecting its strategic expansion into international markets, which could enhance brand visibility and market share.
See More
Market Update: S&P 500 Declines and Upcoming CPI Data
- CPI Expectations: The consumer price index, set to be released at 8:30 a.m. ET on Friday, is expected to show a month-over-month increase of 0.3% and a year-over-year rise of 2.5%, which could significantly influence market sentiment and lead investors to reassess their risk appetite.
- Moderna Stock Fluctuations: Moderna's shares have surged 50% over the past three months, closing at $40.11 on Thursday, although this remains significantly lower than the pandemic peak of $497, indicating ongoing volatility in biotech stocks that investors are closely monitoring.
- Wendy's Stock Decline: Wendy's shares fell 7.7% on Thursday, down 55% from their 52-week high, highlighting the persistent pressures facing the fast-food industry, which may impact its future market performance.
- Retail Sector Dynamics: The Amplify Online Retail ETF dropped nearly 4% on Thursday, now down 19.5% from its September high, reflecting weakness in the retail market, especially after experiencing five consecutive weeks of declines, which could negatively affect overall consumer confidence.
See More
Ulta Beauty's Bullish Outlook, Arista Networks Faces Challenges
- Ulta Beauty Growth Potential: Ulta Beauty's stock has surged approximately 70% over the past 12 months, with its diverse product line ranging from mass-market to luxury brands attracting more consumers and enhancing market competitiveness.
- Increased Consumer Engagement: By boosting foot traffic, Ulta is driving organic sales growth, with retail sales up 3% year-over-year, indicating strong consumer demand for its products.
- Loyalty Program as Growth Driver: Ulta's loyalty program effectively attracts customers, increasing their shopping frequency and thereby enhancing market share and shareholder returns.
- Arista Networks Risks Emerging: Arista faces margin compression and high customer concentration issues; despite a backlog of $18.5 billion in orders, intense competition threatens its profitability.
See More
e.l.f. Beauty Surprises with Q3 Results, Stock Reversal Presents Buying Opportunity
- Significant Sales Growth: e.l.f. Beauty reported a 38% year-over-year sales increase in Q3 2023, reaching $489.5 million, significantly exceeding the analyst consensus of $460 million, indicating robust market demand and brand appeal.
- Enhanced Profitability: Adjusted earnings per share (EPS) surged 68% from $0.74 to $1.24, surpassing the analyst expectation of $0.72, reflecting the company's success in cost control and operational efficiency.
- Market Share Expansion: The e.l.f. brand gained 130 basis points in the mass cosmetics market, with U.S. and international revenues rising 36% and 44% respectively, despite weak consumption in the U.K., showcasing the brand's global appeal.
- Optimistic Outlook: The company raised its fiscal 2026 sales guidance to a growth range of 22% to 33%, expecting Rhode to contribute $260 million to $265 million in revenue, demonstrating confidence in future growth and strategic positioning.
See More
e.l.f. Beauty Reports Strong Q3 Results Exceeding Expectations
- Significant Sales Growth: e.l.f. Beauty's Q3 sales soared 38% year-over-year to $489.5 million, easily surpassing the analyst consensus of $460 million, indicating strong market demand and brand appeal.
- Improved Profitability: Adjusted earnings per share (EPS) surged 68% from $0.74 to $1.24, exceeding the analyst estimate of $0.72, reflecting the company's success in cost control and operational efficiency.
- Rhode Brand Contribution: The Rhode brand contributed $128 million in revenue during the quarter, bolstered by its successful launch at Sephora, further solidifying e.l.f.'s position in the rapidly growing beauty market.
- Optimistic Outlook: e.l.f. raised its fiscal 2026 sales guidance to an increase of 22% to 33%, with Rhode expected to contribute $260 million to $265 million in revenue, demonstrating the company's confidence in future growth and strategic positioning.
See More
